Contents

Homocysteine Blood Test: What High Homocysteine Means

The homocysteine blood test measures an amino acid that rises when B12, folate or B6 runs low. Learn normal levels and what high homocysteine means.

Updated August 26, 202612 min readWritten by the Blood Analysis Team · Reviewed and verified by Julien Priour

Homocysteine is an amino acid your body makes from another amino acid, methionine. To recycle it, your cells need three B vitaminsfolate (B9), B12, and B6. When one runs short, homocysteine builds up in the blood, a state called hyperhomocysteinemia, or simply high homocysteine. The homocysteine blood test measures that level. Its most useful job is spotting a B-vitamin deficiency, but it also carries a widely misunderstood link to heart disease. This guide covers normal homocysteine levels, what a high result means, the causes worth chasing, and why lowering the number with vitamins has not paid off as expected. Homocysteine is best read alongside your B vitamins in a broader vitamin panel.

Key takeaways

  • Homocysteine is a sulfur-containing amino acid from methionine metabolism; recycling it depends on folate (B9), B12, and B6.1
  • A common fasting reference is ~5–15 µmol/L; moderate elevation 15–30, intermediate 30–100, and severe > 100 µmol/L (homocystinuria) — values vary by lab, age, and sex.23
  • High homocysteine most often signals a deficiency in folate (B9), B12, or B6 — and also flags kidney disease, hypothyroidism, the MTHFR gene variant, smoking, age, or certain drugs.31
  • It is a cardiovascular risk marker, but lowering homocysteine with B vitamins has not reduced heart attacks or deaths in large trials; only stroke shows a small benefit. It is not a proven treatment target.45
  • So the test is not recommended for routine cardiovascular screening; it is reserved for specific situations (suspected deficiency, unexplained clots, inherited disease).67
  • High homocysteine is not a tumor marker: it speaks to vitamins, kidneys, and genetics, not cancer.

What is homocysteine?

Homocysteine is a sulfur-containing amino acid your body builds from methionine, supplied by dietary protein (meat, fish, eggs, dairy). It is not meant to accumulate — it is recycled almost immediately by two pathways. The first remethylates it back into methionine using folate (vitamin B9) and vitamin B12; the second converts it into cysteine using vitamin B6. These reactions run on enzymes, including the well-known MTHFR (methylenetetrahydrofolate reductase).13

If one of those vitamins is missing, or an enzyme works poorly, homocysteine is no longer cleared properly and rises. That is why a high level is, above all, a signal pointing toward a vitamin shortfall or a metabolic problem — not a disease in itself.

Homocysteine is not cysteine. Don't confuse homocysteine (the marker measured here) with cysteine, a related amino acid found in many proteins. This guide is about total plasma homocysteine, measured in the blood.

Why the test is done

Unlike routine panels, homocysteine is not tested by default. Your clinician may order it in targeted situations:76

  • to work up a suspected folate or B12 deficiency — homocysteine rises when these vitamins run low, so it can confirm a borderline result alongside B12 and folate;
  • after a blood clot (deep-vein thrombosis, pulmonary embolism) or a stroke that occurs without an obvious cause, especially in a younger person;
  • when an inherited metabolic disorder (homocystinuria) is suspected, often in newborns or children;
  • occasionally in a recurrent-pregnancy-loss or fertility work-up, on specialist advice.

Outside these indications it adds little: this is not a mass cardiovascular screening test, and major U.S. sources advise against ordering it that way.6

How the test is done

The homocysteine test is a standard venous blood draw, usually done fasting (typically 8–12 hours), because a protein-rich, high-methionine meal can push the level up transiently. The sample also needs to reach the lab quickly or be chilled: red blood cells keep releasing homocysteine after the draw, falsely raising the result if the tube sits at room temperature. Follow your order's instructions.2 If your clinician is chasing a deficiency, expect B12 and folate to be measured at the same time.

Normal ranges

Below are indicative adult reference values for fasting total plasma homocysteine. They vary by lab, age, and sex (men run slightly higher) — always compare against the range printed on your report.

StatusHomocysteine (fasting)Unit
Normal~5 – 15µmol/L
Moderate elevation15 – 30µmol/L
Intermediate elevation30 – 100µmol/L
Severe elevation> 100 (homocystinuria)µmol/L

Units: homocysteine is reported in µmol/L worldwide, so U.S. and European results are directly comparable — no conversion needed. Some labs set the upper limit at 12 rather than 15 µmol/L, and values climb modestly with age, in men, and after menopause.23 Only your clinician can interpret it in your context.

A low homocysteine carries no worrying meaning: it usually reflects good folate and B12 status (a rich diet, supplements, or pregnancy, when levels normally fall) and needs no treatment.

High homocysteine: causes

A high homocysteine should prompt a search for a cause — and the first place to look is your B vitamins.31

  • B-vitamin deficiency — the most common and most useful finding. A shortage of folate (B9), B12, or, less often, B6 is the leading reason homocysteine rises, and the easiest to correct. A high homocysteine with a low or borderline B12 or folate points to a deficiency worth treating, and can even help settle a borderline B12 — it rises in both deficiencies, while methylmalonic acid rises only in B12 deficiency, which tells them apart.3
  • Kidney disease. The kidneys clear homocysteine, so reduced filtration raises it — one reason chronic kidney disease is a leading cause of elevation.1
  • Hypothyroidism — an underactive thyroid can lift homocysteine.
  • The MTHFR gene variant (especially C677T), which slows homocysteine recycling — most of all when folate intake is low.8
  • Age, smoking, heavy alcohol use, and certain medications (for example methotrexate, some anti-seizure drugs).3
  • Far more rarely, the inherited disorder homocystinuria, which produces the highest levels of all (often > 100 µmol/L).

Importantly, high homocysteine is not a tumor marker. It reflects your vitamin status, kidneys, and genetics — not cancer.

Homocysteine and heart disease (what the evidence really says)

A high homocysteine is associated with a higher risk of cardiovascular disease — atherosclerosis, blood clots, and stroke — particularly in marked elevations. As a statistical marker, that link is real.19

But association is not the whole story. The obvious next step — lower homocysteine with B vitamins and watch heart attacks fall — was tested in large randomized trials. It largely did not work. The Cochrane review, updated in 2017, pooled 15 trials and 71,422 participants: against placebo, no difference in heart attacks (RR 1.02, 95% CI 0.95–1.10) or death from any cause (RR 1.01, 0.96–1.06), both on high-quality evidence.45

One exception deserves to be stated honestly: stroke. The same review found a small reduction — 4.3% versus 5.1%, RR 0.90 (0.82–0.99), across 10 trials and 44,224 participants, also high-quality evidence: roughly 5 strokes avoided per 1,000 people treated for several years. The authors urge caution, since the reduction may be as little as 1%. And a 2024 meta-analysis of 21 folic-acid trials (115,559 participants) found that same 10% only where flour is not fortified with folic acid — with no effect (RR 1.04) where it is, as in the United States since 1998.10

So homocysteine is a marker, not a proven treatment target. Lowering the number "to fix the number" has not been shown to protect the heart, and the stroke signal is too slim — and too tied to unfortified populations — to justify supplementing on your own. That is why homocysteine is not recommended for routine cardiovascular screening: the value rarely changes what your clinician does about heart risk, which is driven instead by your cholesterol, blood pressure, and other cardiac markers.

The practical distinction: if a high homocysteine uncovers a genuine B12 or folate deficiency, treating it is worthwhile in its own right — for the anemia, the nerves, the fatigue. What has not been shown to help is treating the homocysteine level as if it were the disease.

Homocystinuria and MTHFR

Homocystinuria is a rare, serious inherited disorder — most often a deficiency of the enzyme cystathionine beta-synthase — that blocks homocysteine breakdown and drives levels to extreme highs. Untreated, it causes dislocated eye lenses, skeletal abnormalities, developmental problems, and a high risk of blood clots from a young age.11 It is picked up on newborn screening in the United States and managed by specialists with a low-methionine diet, B6, betaine, and folate. It is a different thing entirely from the mild elevations seen on a routine draw.

MTHFR polymorphisms are something else entirely, and heavily over-hyped. The common C677T variant slightly reduces enzyme activity and can nudge homocysteine up, especially when folate intake is low.812 But it is extremely common — a large share of the population carries at least one copy — and on its own it is not a disease. Routine MTHFR testing is not recommended for most people, including for cardiovascular risk or recurrent miscarriage: the result rarely changes management. Ensuring adequate folate matters far more than the genotype.

When to see a doctor

Homocysteine is rarely something to act on by yourself. Talk to your clinician if your result is above your lab's range, particularly when a B12 or folate deficiency might explain it — that's the finding worth acting on, alongside your diet, symptoms, and medications. Seek prompt advice if a high homocysteine turns up after an unexplained blood clot or stroke, or in the work-up of a possible inherited disorder. Any supplementation, and its dose, should be decided with a clinician, not started to chase a number. Symptoms of a B12 shortfall (tingling, numbness, brain fog, fatigue) deserve attention regardless of the homocysteine value.1

Recent research

According to recent PubMed-indexed publications:

  • Lowering homocysteine does not protect the heart. The Cochrane review, updated in 2017 (15 trials, 71,422 participants), confirms that B6, B9, or B12 reduce neither heart attacks nor mortality, on high-quality evidence; the only favorable result is a small one on stroke (RR 0.90).4 A meta-analysis of B vitamins and cardiovascular disease agrees on major events.5 (Martí-Carvajal AJ et al., Cochrane Database Syst Rev, 2017 — DOI.)
  • A marker to order selectively. A clinical review notes that moderate elevation (15–30 µmol/L) is only a weak predictor of risk, whereas intermediate/severe elevation (> 30 µmol/L) more often reflects a B12/folate deficiency or an under-diagnosed inherited cause — arguing for targeted rather than blanket testing.7 (Guéant JL et al., Thromb Haemost, 2023 — DOI.)
  • Homocysteine and the brain. High homocysteine is associated with cognitive decline and dementia; some trials in at-risk, deficient subjects suggest a slowed decline, but the benefit remains debated and does not justify blanket supplementation.13
  • The genetics, in context. The MTHFR C677T variant raises homocysteine mainly when folate intake is inadequate, and its role in vascular events stays modulated by vitamin status — reinforcing that folate sufficiency matters more than the genotype itself.8

These findings concern diagnosis and research; they do not authorize self-medication and do not replace your physician's advice.

Get your homocysteine interpreted by AI DiagMe

A homocysteine level is never read alone: its meaning depends on your B12 and folate status, your kidney function, your thyroid, your medications, and your context. That cross-reading is what gives the result its real value.

👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.

Frequently asked questions

What is a homocysteine blood test?
It measures total plasma homocysteine, an amino acid your body makes from methionine. Recycling it needs folate (B9), B12, and B6, so when one runs short homocysteine builds up — which is why the test is most useful for detecting a B-vitamin deficiency.
What is a normal homocysteine level?
Indicatively 5–15 µmol/L fasting, with slightly higher values in men and with age. Above 15 µmol/L is hyperhomocysteinemia (moderate to 30, intermediate 30–100, severe beyond). Ranges vary by lab, so read the one on your report.
What does high homocysteine mean?
Most often a deficiency in folate (B9), B12, or B6 — sometimes kidney disease, hypothyroidism, smoking, age, or the MTHFR gene variant. It is an associated cardiovascular risk marker, but not a disease in itself: your clinician should find the cause.
Does high homocysteine cause heart disease?
It is associated with higher cardiovascular risk, but lowering it with B vitamins has not reduced heart attacks or deaths in large trials — only strokes, and only slightly. So homocysteine is treated as a marker, not a proven treatment target, and it is not recommended for routine heart screening.
How do you lower homocysteine?
By correcting the cause: if a confirmed folate, B12, or B6 deficiency is behind it, supplementing brings the level down. But note that lowering homocysteine itself has not been shown to cut heart attacks or deaths — so you treat the deficiency (worthwhile on its own), not the number. Any supplement and dose should be decided with a clinician.
Do I need MTHFR gene testing?
For most people, no. The common C677T variant is frequent and, by itself, not a disease; testing rarely changes management. Ensuring adequate folate matters far more.
Is high homocysteine a sign of cancer?
No. Homocysteine is not a tumor marker. It reflects your B-vitamin status, your kidneys, and your genetics — not a tumor.

Bottom line

The homocysteine blood test measures an amino acid recycled by folate (B9), B12, and B6 — so a high level is, above all, a signal of a B-vitamin deficiency (or a kidney, thyroid, or genetic problem). Keep the ballpark in mind (~5–15 µmol/L fasting, lab-dependent), and keep the honest part too: lowering it with B vitamins has not been shown to protect the heart, and the small stroke benefit does not make it a treatment target. It is not a cancer marker, and MTHFR testing is rarely needed. No value is read alone — your whole profile counts, which is what AI DiagMe provides, alongside your physician.

Sources

Official sources and peer-reviewed publications (PubMed) used for this guide:

Footnotes

  1. Guieu R, Ruf J, Mottola G. Hyperhomocysteinemia and cardiovascular diseases. Ann Biol Clin (Paris), 2022. PubMed · DOI 2 3 4 5 6 7

  2. MedlinePlus (U.S. National Library of Medicine, NIH) — Homocysteine Test. medlineplus.gov 2 3

  3. Kumar A, Palfrey HA, Pathak R, et al. Hyperhomocysteinemia. StatPearls, NCBI Bookshelf, updated 2024. Bookshelf ID NBK554408. bookshelf 2 3 4 5 6 7

  4. Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev, 2017;8(8):CD006612. Third update of the review, superseding the 2015 version (pub4): 15 randomized trials, 71,422 participants. Versus placebo, no difference in myocardial infarction (RR 1.02, 95% CI 0.95–1.10; 12 trials, N = 46,699) or all-cause death (RR 1.01, 0.96–1.06; 11 trials, N = 44,817), both high-quality evidence; a reduction in stroke (4.3% vs 5.1%; RR 0.90, 95% CI 0.82–0.99; I² = 8%; 10 trials, N = 44,224), also high-quality, which the authors themselves call a weak result to be viewed with caution. PubMed · DOI 2 3

  5. Miao Y, Guo Y, Chen Y, et al. The effect of B-vitamins on the prevention and treatment of cardiovascular diseases: a systematic review and meta-analysis. Nutr Rev, 2024. PubMed · DOI 2 3

  6. Testing.com — Homocysteine Test. testing.com 2 3

  7. Guéant JL, Guéant-Rodriguez RM, Oussalah A, et al. Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials. Thromb Haemost, 2023. PubMed · DOI 2 3

  8. Hou HM, Qin XJ, Zhao HY. MTHFR C677T polymorphism, homocysteine, burden, and location of AMI and ACI. Eur Rev Med Pharmacol Sci, 2023. PubMed · DOI 2 3

  9. Wu DF, Yin RX, Deng JL. Homocysteine, hyperhomocysteinemia, and H-type hypertension. Eur J Prev Cardiol, 2024. PubMed · DOI

  10. Zhang N, Zhou Z, Chi X, et al. Folic acid supplementation for stroke prevention: A systematic review and meta-analysis of 21 randomized clinical trials worldwide. Clin Nutr, 2024;43(7):1706-1716. Twenty-one trials, 115,559 participants: folic acid cut stroke risk by 10% (RR 0.90, 95% CI 0.83–0.98). In subgroup analysis — exploratory by nature — the effect was confined to areas without fortified or only partly fortified grain (RR 0.83, 95% CI 0.75–0.93) versus RR 1.04 where grain is fortified (P for interaction = 0.003), and was unchanged by the size of the homocysteine reduction. PubMed · DOI

  11. MedlinePlus Genetics (U.S. National Library of Medicine, NIH) — Homocystinuria. medlineplus.gov

  12. MedlinePlus Genetics (U.S. National Library of Medicine, NIH) — MTHFR gene. medlineplus.gov

  13. Smith AD, Refsum H. Homocysteine, B Vitamins, and Cognitive Impairment. Annu Rev Nutr, 2016. PubMed · DOI

Medical disclaimer. This article is provided for informational and educational purposes only; it is not medical advice and does not replace a consultation. Reference ranges vary by laboratory and method: only your physician can interpret your results in your specific context.